Many employers reported that use was higher than expected and covering them significantly increased prescription drug cost
In addition, even if our results of operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in such reports, those results or developments may not be indicative of results or developments in subsequent periods
Semaglutide is distinguished from native GLP-1 by three modifications
Arizona law governing MDs says it is unprofessional conduct if they or their staff, employer, or representative commits false, fraudulent, deceptive, or misleading advertising. For DOs in Arizona, unprofessional conduct includes advertising in a false, deceptive, or misleading manner. Novo Nordisk, the manufacturer of Wegovy has filed multiple lawsuits against weight loss clinics, medspas, and compounding pharmacies alleging deceptive, unlawful, unfair, and dangerous practices in connection with the marketing and sales of compounded semaglutide